Ultragenyx Pharmaceutical
RARE
#3251
Rank
NZ$6.16 B
Marketcap
$63.82
Share price
-4.26%
Change (1 day)
-18.66%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -$16.92

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$18.05. In 2022 the company made an earnings per share (EPS) of -$17.82 a decrease over its 2021 EPS that were of -$11.83.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$16.92-5.03%
2022-$17.8250.67%
2021-$11.83113.69%
2020-$5.53-55.9%
2019-$12.5582.56%
2018-$6.87-45.15%
2017-$12.5314.68%
2016-$10.9357.36%
2015-$6.9469.83%
2014-$4.0915.22%
2013-$3.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.37-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.13-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.97-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.20-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA